Tom Evans

822 total citations
21 papers, 302 citations indexed

About

Tom Evans is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, Tom Evans has authored 21 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 7 papers in Infectious Diseases and 7 papers in Immunology. Recurrent topics in Tom Evans's work include Tuberculosis Research and Epidemiology (5 papers), Immunotherapy and Immune Responses (5 papers) and Hepatitis B Virus Studies (3 papers). Tom Evans is often cited by papers focused on Tuberculosis Research and Epidemiology (5 papers), Immunotherapy and Immune Responses (5 papers) and Hepatitis B Virus Studies (3 papers). Tom Evans collaborates with scholars based in United Kingdom, United States and South Africa. Tom Evans's co-authors include Tom Sumner, Chen Chen, Rebecca C. Harris, Vicky Cárdenas, Richard G. White, Gwenan M. Knight, John D. Jones, Justin J. Leong, Daniel A. Portnoy and Thomas W. Dubensky and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Tom Evans

18 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tom Evans United Kingdom 9 168 137 99 47 40 21 302
Kuan‐Hsiang Gary Huang United States 10 126 0.8× 154 1.1× 103 1.0× 51 1.1× 26 0.7× 31 429
Gabriele Forcina Italy 12 128 0.8× 184 1.3× 214 2.2× 20 0.4× 27 0.7× 24 415
Eric Olausson Sweden 4 227 1.4× 157 1.1× 94 0.9× 34 0.7× 32 0.8× 7 509
Hannah L. Itell United States 14 165 1.0× 140 1.0× 166 1.7× 71 1.5× 9 0.2× 23 432
Sam M. Murray United Kingdom 5 222 1.3× 72 0.5× 56 0.6× 64 1.4× 25 0.6× 6 357
Lei Duan China 9 223 1.3× 64 0.5× 96 1.0× 67 1.4× 29 0.7× 25 446
Renato Maserati Italy 14 263 1.6× 81 0.6× 139 1.4× 31 0.7× 15 0.4× 24 452
Martin Dupuy France 10 84 0.5× 50 0.4× 179 1.8× 27 0.6× 14 0.3× 15 304
Meagan E. Deming United States 9 486 2.9× 90 0.7× 97 1.0× 66 1.4× 10 0.3× 16 595
Johan Ringlander Sweden 12 128 0.8× 40 0.3× 106 1.1× 73 1.6× 31 0.8× 33 380

Countries citing papers authored by Tom Evans

Since Specialization
Citations

This map shows the geographic impact of Tom Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Evans more than expected).

Fields of papers citing papers by Tom Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Evans. The network helps show where Tom Evans may publish in the future.

Co-authorship network of co-authors of Tom Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Tom Evans. A scholar is included among the top collaborators of Tom Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom Evans. Tom Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
García‐Basteiro, Alberto L., Richard G. White, Dereck Tait, et al.. (2022). End-point definition and trial design to advance tuberculosis vaccine development. European Respiratory Review. 31(164). 220044–220044. 12 indexed citations
3.
Hill, Adrian V. S., Mark Tuthill, Federica Cappuccini, et al.. (2021). Abstract IA11: Viral vectored vaccines for prostate cancer. Cancer Immunology Research. 9(2_Supplement). IA11–IA11.
4.
5.
Chinnakannan, Senthil, Tamsin Cargill, Timothy Donnison, et al.. (2020). The Design and Development of a Multi-HBV Antigen Encoded in Chimpanzee Adenoviral and Modified Vaccinia Ankara Viral Vectors; A Novel Therapeutic Vaccine Strategy against HBV. Vaccines. 8(2). 184–184. 26 indexed citations
6.
Harris, Rebecca C., Tom Sumner, Gwenan M. Knight, et al.. (2019). Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study. The Lancet Global Health. 7(2). e209–e218. 45 indexed citations
7.
8.
Dis, Erik Van, Kimberly M. Sogi, Chris S. Rae, et al.. (2018). STING-Activating Adjuvants Elicit a Th17 Immune Response and Protect against Mycobacterium tuberculosis Infection. Cell Reports. 23(5). 1435–1447. 91 indexed citations
9.
Harris, Rebecca C., Tom Sumner, Gwen Knight, et al.. (2018). New tuberculosis vaccines – modelling the impact of age targeted vaccination in China and implications for vaccine development. 2 indexed citations
10.
Redchenko, Irina, Federica Cappuccini, Emily Pollock, et al.. (2018). VANCE: First-in-human phase I study of a novel ChAdOx1-MVA 5T4 vaccine in low and intermediate risk prostate cancer.. Journal of Clinical Oncology. 36(15_suppl). 3018–3018. 2 indexed citations
11.
Emini, Emilio A., Michael Watson, John Donnelly, et al.. (2017). Human capital gaps in vaccine development: an issue for global vaccine development and global health. Annals of the New York Academy of Sciences. 1395(1). 3–11. 8 indexed citations
12.
Nyendak, Melissa, Gwendolyn Swarbrick, Meghan Cansler, et al.. (2016). Adenovirally-Induced Polyfunctional T Cells Do Not Necessarily Recognize the Infected Target: Lessons from a Phase I Trial of the AERAS-402 Vaccine. Scientific Reports. 6(1). 36355–36355. 25 indexed citations
13.
Bailey, Damian M., Tom Evans, Richard White, et al.. (2016). Intervisceral artery origins in patients with abdominal aortic aneurysmal disease; evidence for systemic vascular remodelling. Experimental Physiology. 101(8). 1143–1153. 4 indexed citations
14.
Parkinson, Lynne, et al.. (2016). Red cell distribution width as a predictor of 30 mortality, a single centre review. International Journal of Surgery. 36. S70–S70.
15.
Ellis, Ruth D., Mark Hatherill, Dereck Tait, et al.. (2015). Innovative clinical trial designs to rationalize TB vaccine development. Tuberculosis. 95(3). 352–357. 23 indexed citations
16.
Evans, Tom, et al.. (2015). Subclavian Artery Pseudoaneurysm Formation 3 Months after a Game of Rugby Union. SHILAP Revista de lepidopterología. 2015. 1–3. 1 indexed citations
17.
Evans, Tom, et al.. (1988). Computerised updating of clinical summaries: new opportunities for clinical practice and research?. BMJ. 297(6662). 1504–1506. 25 indexed citations
18.
Ribeiro, P., Ralph N. Sapsford, Tom Evans, George E. Parcharidis, & C M Oakley. (1984). Constrictive pericarditis as a complication of coronary artery bypass surgery.. Heart. 51(2). 205–210. 18 indexed citations
19.
Evans, Tom, et al.. (1971). Spring's Awakening. Educational Theatre Journal. 23(2). 212–212.
20.
Jones, John D. & Tom Evans. (1959). ANTERIOR SACRAL MENINGOCELE. BJOG An International Journal of Obstetrics & Gynaecology. 66(3). 477–479. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kuan‐Hsiang Gary Huang Breakdown of academic impact, for papers by Gabriele Forcina Breakdown of academic impact, for papers by Eric Olausson Breakdown of academic impact, for papers by Hannah L. Itell Breakdown of academic impact, for papers by Sam M. Murray Breakdown of academic impact, for papers by Lei Duan Breakdown of academic impact, for papers by Renato Maserati Breakdown of academic impact, for papers by Martin Dupuy Breakdown of academic impact, for papers by Meagan E. Deming Breakdown of academic impact, for papers by Johan Ringlander
Rankless by CCL
2026